RNAI Insider Trading Activity and SEC Form 4 Filings
RNAI insider trading summary
No open-market insider purchases or sales of Sirna Therapeutics Inc (RNAI) have been reported on SEC Form 4 in the past 12 months.
Latest RNAI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 25, 2006 | Gregory L Weaver | Senior Vice President and CFO | Buy | $76K (15,000 @ $5.06) |
| Jul 6, 2005 | Mrna Fund II LP | 10% Owner | Buy | $20K (12,418 @ $1.60) |
| Jul 6, 2005 | James Niedel | Director | Buy | $4.6M (2,895,406 @ $1.60) |
| Jul 6, 2005 | Oxford Bioscience Partners IV LP | 10% Owner | Buy | $20K (12,418 @ $1.60) |
| Jul 6, 2005 | Mrna Fund II LP | 10% Owner | Buy | $2.0M (1,237,582 @ $1.60) |
| Jul 6, 2005 | R Scott Greer | Director | Buy | $60K (37,500 @ $1.60) |
| Jul 6, 2005 | Venrock Entrepreneurs Fund III LP | 10% Owner | Buy | $40K (24,999 @ $1.60) |
| Jul 6, 2005 | James Niedel | Director | Buy | $214K (133,712 @ $1.60) |
| Jul 6, 2005 | Vef Management III LLC | 10% Owner | Buy | $40K (24,999 @ $1.60) |
| Jul 6, 2005 | Oxford Bioscience Partners IV LP | 10% Owner | Buy | $2.0M (1,237,582 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.